1. A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma. Issue 2 (30th November 2021) Authors: Cornell, Robert Frank; Baz, Rachid; Richter, Joshua R.; Rossi, Adriana; Vogl, Dan T.; Chen, Christine; Shustik, Chaim; Alvarez, Mariano J.; Shen, Yao; Unger, T. J.; Ben‐Shahar, Osnat; Wang, Hongwei; Baloglu, Erkan; Senapedis, William; Ma, Xiwen; Landesman, Yosef; Bai, Xiang; Bader, Justin; Xu, Ho... Journal: American journal of hematology Issue: Volume 97:Issue 2(2022) Page Start: E54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Central nervous system involvement by multiple myeloma: A multi‐institutional retrospective study of 172 patients in daily clinical practice. Issue 6 (24th April 2016) Authors: Jurczyszyn, Artur; Grzasko, Norbert; Gozzetti, Alessandro; Czepiel, Jacek; Cerase, Alfonso; Hungria, Vania; Crusoe, Edvan; Silva Dias, Ana Luiza Miranda; Vij, Ravi; Fiala, Mark A.; Caers, Jo; Rasche, Leo; Nooka, Ajay K.; Lonial, Sagar; Vesole, David H.; Philip, Sandhya; Gangatharan, Shane; Druzd‐... Journal: American journal of hematology Issue: Volume 91:Issue 6(2016:Jun.) Page Start: 575 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Continuous lenalidomide and low‐dose dexamethasone in patients with transplant‐ineligible newly diagnosed MM: FIRST trial subanalysis of Canadian/US patients. (13th October 2020) Authors: Belch, Andrew; Bahlis, Nizar; White, Darrell; Cheung, Matthew; Chen, Christine; Shustik, Chaim; Song, Kevin; Tosikyan, Axel; Dispenzieri, Angela; Anderson, Kenneth; Brown, Diane; Robinson, Suzanne; Srinivasan, Shankar; Facon, Thierry Journal: Cancer medicine Issue: Volume 9:Number 23(2020) Page Start: 8923 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients. Issue 9 (1st September 2016) Authors: Jurczyszyn, Artur; Olszewska-Szopa, Magdalena; Hungria, Vania; Crusoe, Edvan; Pika, Tomas; Delforge, Michel; Leleu, Xavier; Rasche, Leo; Nooka, Ajay K.; Druzd-Sitek, Agnieszka; Walewski, Jan; Davila, Julio; Caers, Jo; Maisnar, Vladimir; Gertz, Morie; Gentile, Massimo; Fantl, Dorotea; Mele, Giusep... Journal: Leukemia & lymphoma Issue: Volume 57:Issue 9(2016:Sep.) Page Start: 2071 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Final analysis of a phase 1/2b study of ibrutinib combined with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma. Issue 3 (11th March 2020) Authors: Chari, Ajai; Cornell, Robert F.; Gasparetto, Cristina; Karanes, Chatchada; Matous, Jeffrey V.; Niesvizky, Ruben; Lunning, Matthew; Usmani, Saad Z.; Anderson, Larry D.; Chhabra, Saurabh; Girnius, Saulius; Shustik, Chaim; Stuart, Robert; Lee, Yihua; Salman, Zeena; Liu, Emily; Valent, Jason Journal: Hematological oncology Issue: Volume 38:Issue 3(2020) Page Start: 353 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial. Issue 2 (February 2017) Authors: Dimopoulos, Meletios A; Trotman, Judith; Tedeschi, Alessandra; Matous, Jeffrey V; Macdonald, David; Tam, Constantine; Tournilhac, Olivier; Ma, Shuo; Oriol, Albert; Heffner, Leonard T; Shustik, Chaim; García-Sanz, Ramón; Cornell, Robert F; de Larrea, Carlos Fernández; Castillo, Jorge J; Granell, M... Journal: Lancet oncology Issue: Volume 18:Issue 2(2017:Feb.) Page Start: 241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström's Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study. Issue 1 (1st January 2022) Authors: Buske, Christian; Tedeschi, Alessandra; Trotman, Judith; García-Sanz, Ramón; MacDonald, David; Leblond, Veronique; Mahe, Beatrice; Herbaux, Charles; Matous, Jeffrey V.; Tam, Constantine S.; Heffner, Leonard T.; Varettoni, Marzia; Palomba, M. Lia; Shustik, Chaim; Kastritis, Efstathios; Treon, Stev... Journal: Journal of clinical oncology Issue: Volume 40:Issue 1(2022) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma. (9th May 2017) Authors: Kumar, Shaji; Moreau, Philippe; Hari, Parameswaran; Mateos, Maria‐Victoria; Ludwig, Heinz; Shustik, Chaim; Masszi, Tamas; Spencer, Andrew; Hájek, Roman; Romeril, Kenneth; Avivi, Irit; Liberati, Anna M.; Minnema, Monique C.; Einsele, Hermann; Lonial, Sagar; Berg, Deborah; Lin, Jianchang; Gupta, Ne... Journal: British journal of haematology Issue: Volume 178:Number 4(2017) Page Start: 571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Spontaneous remission and clonal evolution in lenalidomide associated secondary AML. Issue 7 (6th June 2020) Authors: Waller, Daniel D.; Monczak, Yury; Michel, René P.; Shustik, Chaim; Sebag, Michael Journal: Leukemia & lymphoma Issue: Volume 61:Issue 7(2020) Page Start: 1724 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗